Health
Nanobodies inhibit SARS-CoV-2 infection, including emergent variants – Phys.org
Australian researchers have identified neutralizing nanobodies that block the SARS-CoV-2 virus from entering cells in preclinical models.
Australian researchers have identified neutralizing nanobodies that block the SARS-CoV-2 virus from entering cells in preclinical models.
The discovery paves the way for further investigations into nanobody-based treatments for COVID-19.
Published in PNAS, the research is part of a consortium-led effort, bringing together the expertise of Australian academic leaders in infectious diseases and antibody therapeutics at WEHI, the Doherty Institute and the Kirby Institute.
Using alpaca ‘nanobodies’…
-
Noosa News16 hours agoExperts share tiny home warning as interest from young people soars
-
Noosa News22 hours agoKarenia cristata species source of toxins in SA’s algal bloom, scientists believe
-
Noosa News21 hours agoThe Calile Hotel Named on the World’s 50 Best Hotels List
-
Noosa News16 hours agoExpert’s warning as tourists stunned by hundreds of sharks spotted close to shore at Moreton Island, Queensland